N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide

C22H27N3O3S — CID 169296685

IUPACN-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide
SMILESCN1CCc2ccccc2-c2cccc(c2)CC2C(NS(C)(=O)=O)CCN2C1=O
InChIInChI=1S/C22H27N3O3S/c1-24-12-10-17-7-3-4-9-19(17)18-8-5-6-16(14-18)15-21-20(23-29(2,27)28)11-13-25(21)22(24)26/h3-9,14,20-21,23H,10-13,15H2,1-2H3
InChIKeyAPMXWANONOYYIT-UHFFFAOYSA-N
MW413.54 g/mol
LogP2.50
Rot. Bonds2

About N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide

N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide (PubChem CID 169296685) has the molecular formula C22H27N3O3S and a molecular weight of 413.54 g/mol. Its IUPAC name is N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide.

Molecular Properties

Compound NameN-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide
PubChem CID169296685
Molecular FormulaC22H27N3O3S
Molecular Weight413.54 g/mol
Exact Mass413.18
IUPAC NameN-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide
SMILESCN1CCc2ccccc2-c2cccc(c2)CC2C(NS(C)(=O)=O)CCN2C1=O
InChIInChI=1S/C22H27N3O3S/c1-24-12-10-17-7-3-4-9-19(17)18-8-5-6-16(14-18)15-21-20(23-29(2,27)28)11-13-25(21)22(24)26/h3-9,14,20-21,23H,10-13,15H2,1-2H3
InChIKeyAPMXWANONOYYIT-UHFFFAOYSA-N
XLogP2.50
TPSA69.72 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds2
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500413.54
LogP ≤ 52.50
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide?
The IUPAC name of N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide (CID 169296685) is N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide.
What is the SMILES notation for N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide?
The canonical SMILES for N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide is CN1CCc2ccccc2-c2cccc(c2)CC2C(NS(C)(=O)=O)CCN2C1=O.
What is the InChIKey of N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide?
The InChIKey is APMXWANONOYYIT-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H27N3O3S/c1-24-12-10-17-7-3-4-9-19(17)18-8-5-6-16(14-18)15-21-20(23-29(2,27)28)11-13-25(21)22(24)26/h3-9,14,20-21,23H,10-13,15H2,1-2H3.
What are the key properties of N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide?
N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide has a molecular weight of 413.54 g/mol, XLogP of 2.50, 2 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-(10-methyl-11-oxo-10,12-diazatetracyclo[16.3.1.02,7.012,16]docosa-1(21),2,4,6,18(22),19-hexaen-15-yl)methanesulfonamide is sourced from PubChem (CID 169296685), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).